IP Library Patent Application 18548833
Patent Application
App. No. 18/548,833

TRIAZOLYL-METHYL SUBSTITUTED ALPHA-D-GALACTOPYRANOSIDE DERIVATIVES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/548,833
Abstract

The present invention relates to Galectin-3 inhibitors of Formula (I) and pharmaceutically acceptable salts thereof, to pharmaceutical compositions comprising such compounds, and their medical uses.

Claims (208)

1 . A compound of formula (I)

wherein

R P2 represents halogen;

R P3 represents halogen;

R P4 represents halogen, methyl or cyano;

R 1 represents

hydroxy;

C 1-4 -alkoxy;

—O—CO—C 1-3 -alkyl;

O—CO—NH—R N11 wherein R N11 represents hydrogen or C 1-3 -alkyl;

—O—CH 2 —C 1 -fluoroalkyl;

—O—CH 2 - wherein represents a 5-membered heteroaryl wherein said 5-membered heteroaryl independently is unsubstituted or mono-substituted with methyl; or

—O—CH 2 —CO—R 1X wherein R 1X represents

-hydroxy;

C 1-3 -alkoxy;

morpholin-4-yl; or

—NR N21 R N22 wherein R N21 and R N22 both independently represent hydrogen or methyl; or

R N21 and R N22 together with the nitrogen atom to which they are attached form a 4- to 6-membered mono-cyclic heterocycloalkyl selected from azetidine-1-yl, pyrrolidine-1-yl, and piperidine-1-yl, wherein said 4- to 6-membered heterocycloalkyl is mono-substituted with hydroxy;

A represents [1,2,3]triazol-1,4-diyl; and

R 2 represents branched C 3-6 -alkyl wherein said branched C 3-6 -alkyl is

mono-substituted with hydroxy,

mono-substituted with —CO—O—C 1-4 -alkyl, or

mono-substituted with C 1 -fluoroalkyl;

or R 2 represents a saturated 3- to 8-membered mono- or bicyclic group, wherein said mono- or bicyclic group is

mono-cyclic C 3-6 -cycloalkyl,

mono-cyclic 4- to 6-membered heterocycloalkyl containing one ring oxygen atom,

bridged bicyclic C 5-8 -cycloalkyl,

fused bicyclic C 6-8 -cycloalkyl,

spiro-bicyclic C 6-8 -cycloalkyl, or

spiro-bicyclic 7- or 8-membered heterocycloalkyl containing one ring oxygen atom;

wherein said mono-cyclic or bicyclic group independently is

unsubstituted;

mono-substituted with hydroxy;

mono-substituted with C 1-3 -alkyl;

mono-substituted with C 1-3 -alkoxy;

mono-substituted with —C 1-3 -alkylene-OH;

mono-substituted with —C 1-3 -alkylene-O—C 1-3 -alkyl;

mono-substituted with C 1 -fluoroalkyl;

mono-substituted with —NR N1 R N2 , wherein R N1 represents hydrogen, and R N2 represents hydrogen or —CO—O—C 1-4 -alkyl;

mono- or di-substituted with fluoro;

di-substituted wherein one substituent is hydroxy and the other is C 1-3 -alkyl; or

tri-substituted wherein two of said substituents are fluoro; and the remaining substituent is C 1-3 -alkyl or —C 1-3 -alkylene-OH;

or a pharmaceutically acceptable salt thereof.

2 . A compound according to claim 1 , wherein

R P2 represents fluoro or chloro;

R P3 represents fluoro or chloro; and

R P4 represents halogen, methyl or cyano.

or a pharmaceutically acceptable salt thereof.

3 . A compound according to claim 1 , wherein

R P2 represents fluoro;

R P3 represents fluoro; and

R P4 represents fluoro, chloro, bromo, or methyl;

or a pharmaceutically acceptable salt thereof.

4 . A compound according to claim 1 , wherein R 1 represents methoxy;

or a pharmaceutically acceptable salt thereof.

5 . A compound according to claim 1 , wherein A represents [1,2,3]triazol-1,4-diyl wherein R 2 is attached to position 1 of said [1,2,3]triazol-1,4-diyl;

or a pharmaceutically acceptable salt thereof.

6 . A compound according to claim 1 , wherein A represents [1,2,3]triazol-1,4-diyl wherein R 2 is attached to position 4 of said [1,2,3]triazol-1,4-diyl;

or a pharmaceutically acceptable salt thereof.

7 . A compound according to claim 1 , wherein

d) the group A-R 2 represents a group

 selected from:

or

e) the group A-R 2 represents a group

 selected from:

or

f) the group A-R 2 represents a group

 selected from:

or a pharmaceutically acceptable salt thereof.

8 . A compound according to claim 1 , wherein said compound is:

(2R,3R,4S,5R,6R)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-6-((1-((3R,4R)-4-hydroxytetrahydro-2H-pyran-3-yl)-1H-1,2,3-triazol-4-yl)methyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-6-((1-((1R,2R)-2-hydroxycyclopentyl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-6-((1-((1S,2S)-2-hydroxycyclopentyl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-6-((1-(1-(hydroxymethyl)cyclopropyl)-1H-1,2,3-triazol-4-yl)methyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-6-((1-(1-(hydroxymethyl)cyclopentyl)-1H-1,2,3-triazol-4-yl)methyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxy-6-((1-(3-methyloxetan-3-yl)-1H-1,2,3-triazol-4-yl)methyl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxy-6-((1-(1-(methoxymethyl)cyclopropyl)-1H-1,2,3-triazol-4-yl)methyl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-6-((1-(4-hydroxybicyclo [2.2.2]octan-1-yl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-6-((1-(1-hydroxy-2-methylpropan-2-yl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

methyl 2-(4-(((2R,3R,4S,5R,6R)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-5-hydroxy-6-(hydroxy methyl)-3-methoxytetrahydro-2H-pyran-2-yl)methyl)-1H-1,2,3-triazol-1-yl)-2-methylpropanoate;

(2R,3R,4S,5R,6R)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-6-((1-(1-(hydroxymethyl)cyclobutyl)-1H-1,2,3-triazol-4-yl)methyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-6-((1-(bicyclo[1.1.1]pentan-1-yl)-1H-1,2,3-triazol-4-yl)methyl)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxy-6-((1-(1-methylcyclobutyl)-1H-1,2,3-triazol-4-yl)methyl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxy-6-((1-(3-methylbicyclo[1.1.1]pentan-1-yl)-1H-1,2,3-triazol-4-yl)methyl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-6-((1-(3,3-difluoro-1-methylcyclobutyl)-1H-1,2,3-triazol-4-yl)methyl)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-6-((1-(2-oxaspiro[3.3]heptan-6-yl)-1H-1,2,3-triazol-4-yl)methyl)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-6-((1-((1RS,2SR)-2-isopropylcyclopropyl)-1H-1,2,3-triazol-4-yl)methyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-6-((1-(3,3-difluoro-1-(hydroxymethyl)cyclobutyl)-1H-1,2,3-triazol-4-yl)methyl)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-6-((1-((1S,3S)-3-hydroxy-1-methylcyclobutyl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-6-((1-((1R,5S)-bicyclo[3.1.0]hexan-6-yl)-1H-1,2,3-triazol-4-yl)methyl)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxy-6-((1-(3-(methoxymethyl)oxetan-3-yl)-1H-1,2,3-triazol-4-yl)methyl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-6-((1-(3-(2-hydroxyethyl) oxetan-3-yl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxy-6-((1-(1-methylcyclopropyl)-1H-1,2,3-triazol-4-yl)methyl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxy-6-((1-(3-(trifluoromethyl)bicyclo[1.1.1]pentan-1-yl)-1H-1,2,3-triazol-4-yl)methyl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-6-((1-(3-fluorobicyclo[1.1.1]pentan-1-yl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxy-6-((1-(spiro[2.3]hexan-5-yl)-1H-1,2,3-triazol-4-yl)methyl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-6-((1-((1R,3R)-3-hydroxy-1-methylcyclobutyl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxy-6-((1-(1-(methoxymethyl)cyclopropyl)-1H-1,2,3-triazol-4-yl)methyl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-6-((1-(1,1-difluoro-2-methylpropan-2-yl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-6-((1-(1-(hydroxymethyl)cyclopropyl)-1H-1,2,3-triazol-4-yl)methyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-6-((1-(1-(hydroxymethyl)cyclopentyl)-1H-1,2,3-triazol-4-yl)methyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-6-((1-(1-(hydroxymethyl)cyclobutyl)-1H-1,2,3-triazol-4-yl)methyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-6-((1-(4-hydroxybicyclo [2.2.2]octan-1-yl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-6-((1-(1-hydroxy-2-methylpropan-2-yl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

methyl 2-(4-(((2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-5-hydroxy-6-(hydroxy methyl)-3-methoxytetrahydro-2H-pyran-2-yl)methyl)-1H-1,2,3-triazol-1-yl)-2-methylpropanoate;

(2R,3R,4S,5R,6R)-6-((1-(bicyclo[1.1.1]pentan-1-yl)-1H-1,2,3-triazol-4-yl)methyl)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxy-6-((1-(1-methylcyclobutyl)-1H-1,2,3-triazol-4-yl)methyl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxy-6-((1-(3-methyloxetan-3-yl)-1H-1,2,3-triazol-4-yl)methyl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxy-6-((1-(3-methylbicyclo[1.1.1]pentan-1-yl)-1H-1,2,3-triazol-4-yl)methyl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxy-6-((1-(3-methoxybicyclo[1.1.1]pentan-1-yl)-1H-1,2,3-triazol-4-yl)methyl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-6-((1-(3,3-difluoro-1-methylcyclobutyl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-6-((1-(2-oxaspiro[3.3]heptan-6-yl)-1H-1,2,3-triazol-4-yl)methyl)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-6-((1-(2-isopropylcyclopropyl)-1H-1,2,3-triazol-4-yl)methyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-6-((1-(3,3-difluoro-1-(hydroxy methyl)cyclobutyl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-6-((1-((1S,3S)-3-hydroxy-1-methylcyclobutyl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-6-((1-((1R,5S)-bicyclo[3.1.0]hexan-6-yl)-1H-1,2,3-triazol-4-yl)methyl)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxy-6-((1-(3-(methoxymethyl)oxetan-3-yl)-1H-1,2,3-triazol-4-yl)methyl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-6-((1-(3-(2-hydroxyethyl) oxetan-3-yl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxy-6-((1-(1-methylcyclopropyl)-1H-1,2,3-triazol-4-yl)methyl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxy-6-((1-(3-(trifluoromethyl)bicyclo[1.1.1]pentan-1-yl)-1H-1,2,3-triazol-4-yl)methyl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-6-((1-(3-fluorobicyclo[1.1.1]pentan-1-yl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxy-6-((1-(spiro[2.3]hexan-5-yl)-1H-1,2,3-triazol-4-yl)methyl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-6-((1-((1R,3R)-3-hydroxy-1-methylcyclobutyl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-2-(hydroxymethyl)-6-((1-(1-(hydroxymethyl)cyclopentyl)-1H-1,2,3-triazol-4-yl)methyl)-5-methoxy-4-(4-(2,3,4-trifluorophenyl)-1H-1,2,3-triazol-1-yl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-2-(hydroxymethyl)-6-((1-(1-(hydroxymethyl)cyclopropyl)-1H-1,2,3-triazol-4-yl)methyl)-5-methoxy-4-(4-(2,3,4-trifluorophenyl)-1H-1,2,3-triazol-1-yl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-2-(hydroxymethyl)-5-methoxy-6-((1-(1-(methoxymethyl)cyclopropyl)-1H-1,2,3-triazol-4-yl)methyl)-4-(4-(2,3,4-trifluorophenyl)-1H-1,2,3-triazol-1-yl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-6-((1-(bicyclo[1.1.1]pentan-1-yl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxy-4-(4-(2,3,4-trifluorophenyl)-1H-1,2,3-triazol-1-yl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-2-(hydroxymethyl)-6-((1-(1-(hydroxymethyl)cyclobutyl)-1H-1,2,3-triazol-4-yl)methyl)-5-methoxy-4-(4-(2,3,4-trifluorophenyl)-1H-1,2,3-triazol-1-yl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-6-((1-(3-fluorobicyclo[1.1.1]pentan-1-yl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxylmethyl)-5-methoxy-4-(4-(2,3,4-trifluorophenyl)-1H-1,2,3-triazol-1-yl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-2-(hydroxymethyl)-5-methoxy-6-((1-(3-(trifluoromethyl)bicyclo[1.1.1]pentan-1-yl)-1H-1,2,3-triazol-4-yl)methyl)-4-(4-(2,3,4-trifluorophenyl)-1H-1,2,3-triazol-1-yl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-6-((1-(3,3-difluoro-1-methylcyclobutyl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxy-4-(4-(2,3,4-trifluorophenyl)-1H-1,2,3-triazol-1-yl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-6-((1-(3,3-difluoro-1-(hydroxymethyl)cyclobutyl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxy-4-(4-(2,3,4-trifluorophenyl)-1H-1,2,3-triazol-1-yl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-6-((1-(2-oxaspiro[3.3]heptan-6-yl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxy-4-(4-(2,3,4-trifluorophenyl)-1H-1,2,3-triazol-1-yl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-6-((1-((1R,3R)-3-hydroxy-1-methylcyclobutyl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxy-4-(4-(2,3,4-trifluorophenyl)-1H-1,2,3-triazol-1-yl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-6-((1-((1S,3S)-3-hydroxy-1-methylcyclobutyl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxy-4-(4-(2,3,4-trifluorophenyl)-1H-1,2,3-triazol-1-yl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-2-(hydroxymethyl)-5-methoxy-6-((1-(3-(methoxymethyl)oxetan-3-yl)-1H-1,2,3-triazol-4-yl)methyl)-4-(4-(2,3,4-trifluorophenyl)-1H-1,2,3-triazol-1-yl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-6-((1-(3-(2-hydroxyethyl)oxetan-3-yl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxy-4-(4-(2,3,4-trifluorophenyl)-1H-1,2,3-triazol-1-yl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-2-(hydroxymethyl)-5-methoxy-6-((1-(1-methylcyclopropyl)-1H-1,2,3-triazol-4-yl) methyl)-4-(4-(2,3,4-trifluorophenyl)-1H-1,2,3-triazol-1-yl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-bromo-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxy-6-((1-(3-methyloxetan-3-yl)-1H-1,2,3-triazol-4-yl)methyl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-bromo-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxy-6-((1-(1-methylcyclobutyl)-1H-1,2,3-triazol-4-yl)methyl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-6-((1-(bicyclo[1.1.1]pentan-1-yl)-1H-1,2,3-triazol-4-yl)methyl)-4-(4-(4-bromo-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-bromo-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxy-6-((1-(1-(methoxymethyl)cyclobutyl)-1H-1,2,3-triazol-4-yl)methyl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-bromo-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-6-((1-(1-(hydroxymethyl)cyclopropyl)-1H-1,2,3-triazol-4-yl)methyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-bromo-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-6-((1-((1S,2S)-2-hydroxycyclopentyl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-6-((4-(1-hydroxycyclobutyl)-1H-1,2,3-triazol-1-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-6-((4-cyclopentyl-1H-1,2,3-triazol-1-yl)methyl)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-6-((4-(1-hydroxycyclopentyl)-1H-1,2,3-triazol-1-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-6-((4-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)methyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxy-6-((4-(3-methyloxetan-3-yl)-1H-1,2,3-triazol-1-yl)methyl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-6-((4-(4-hydroxytetrahydro-2H-pyran-4-yl)-1H-1,2,3-triazol-1-yl)methyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-6-((4-(1-hydroxycyclopropyl)-1H-1,2,3-triazol-1-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-6-((4-(1-(hydroxymethyl)cyclopropyl)-1H-1,2,3-triazol-1-yl)methyl)-5-methoxytetrahydro-2H-pyran-3-ol;

tert-butyl (4-(1-(((2R,3R,4S,5R,6R)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-5-hydroxy-6-(hydroxymethyl)-3-methoxytetrahydro-2H-pyran-2-yl)methyl)-1H-1,2,3-triazol-4-yl)bicyclo[2.2.2]octan-1-yl)carbamate;

(2R,3R,4S,5R,6R)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-6-((4-(3-ethyloxetan-3-yl)-1H-1,2,3-triazol-1-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-6-((1-(4-aminobicyclo[2.2.2]octan-1-yl)-1H-1,2,3-triazol-4-yl)methyl)-4-(4-(2,3-difluoro-4-methylphenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-6-((4-(1-hydroxycyclobutyl)-1H-1,2,3-triazol-1-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-6-((4-cyclopentyl-1H-1,2,3-triazol-1-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-6-((4-(1-hydroxycyclopentyl)-1H-1,2,3-triazol-1-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-6-((4-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)methyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxy-6-((4-(3-methyloxetan-3-yl)-1H-1,2,3-triazol-1-yl)methyl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-6-((4-(4-hydroxytetrahydro-2H-pyran-4-yl)-1H-1,2,3-triazol-1-yl)methyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-6-((4-(1-hydroxycyclopropyl)-1H-1,2,3-triazol-1-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-6-((4-(1-(hydroxymethyl)cyclopropyl)-1H-1,2,3-triazol-1-yl)methyl)-5-methoxytetrahydro-2H-pyran-3-ol;

tert-butyl (4-(1-(((2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-5-hydroxy-6-(hydroxy methyl)-3-methoxytetrahydro-2H-pyran-2-yl)methyl)-1H-1,2,3-triazol-4-yl)bicyclo[2.2.2]octan-1-yl) carbamate;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-6-((4-(3-ethyloxetan-3-yl)-1H-1,2,3-triazol-1-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-6-((1-(4-aminobicyclo[2.2.2]octan-1-yl)-1H-1,2,3-triazol-4-yl)methyl)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-6-((4-(1-hydroxycyclobutyl)-1H-1,2,3-triazol-1-yl)methyl)-2-(hydroxymethyl)-5-methoxy-4-(4-(2,3,4-trifluorophenyl)-1H-1,2,3-triazol-1-yl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-6-((4-cyclopentyl-1H-1,2,3-triazol-1-yl)methyl)-2-(hydroxymethyl)-5-methoxy-4-(4-(2,3,4-trifluorophenyl)-1H-1,2,3-triazol-1-yl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-6-((4-(1-hydroxycyclopentyl)-1H-1,2,3-triazol-1-yl)methyl)-2-(hydroxymethyl)-5-methoxy-4-(4-(2,3,4-trifluorophenyl)-1H-1,2,3-triazol-1-yl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-2-(hydroxymethyl)-6-((4-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)methyl)-5-methoxy-4-(4-(2,3,4-trifluorophenyl)-1H-1,2,3-triazol-1-yl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-2-(hydroxymethyl)-5-methoxy-6-((4-(3-methyloxetan-3-yl)-1H-1,2,3-triazol-1-yl) methyl)-4-(4-(2,3,4-trifluorophenyl)-1H-1,2,3-triazol-1-yl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-2-(hydroxymethyl)-6-((4-(4-hydroxytetrahydro-2H-pyran-4-yl)-1H-1,2,3-triazol-1-yl) methyl)-5-methoxy-4-(4-(2,3,4-trifluorophenyl)-1H-1,2,3-triazol-1-yl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-6-((4-(1-hydroxycyclopropyl)-1H-1,2,3-triazol-1-yl)methyl)-2-(hydroxymethyl)-5-methoxy-4-(4-(2,3,4-trifluorophenyl)-1H-1,2,3-triazol-1-yl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-2-(hydroxymethyl)-6-((4-(1-(hydroxymethyl)cyclopropyl)-1H-1,2,3-triazol-1-yl)methyl)-5-methoxy-4-(4-(2,3,4-trifluorophenyl)-1H-1,2,3-triazol-1-yl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-6-((4-(3-ethyloxetan-3-yl)-1H-1,2,3-triazol-1-yl)methyl)-2-(hydroxymethyl)-5-methoxy-4-(4-(2,3,4-trifluorophenyl)-1H-1,2,3-triazol-1-yl)tetrahydro-2H-pyran-3-ol;

tert-butyl (4-(1-(((2R,3R,4S,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3-methoxy-4-(4-(2,3,4-trifluorophenyl)-1H-1,2,3-triazol-1-yl)tetrahydro-2H-pyran-2-yl)methyl)-1H-1,2,3-triazol-4-yl)bicyclo[2.2.2]octan-1-yl)carbamate;

(2R,3R,4S,5R,6R)-6-((1-(4-aminobicyclo[2.2.2]octan-1-yl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxy-4-(4-(2,3,4-trifluorophenyl)-1H-1,2,3-triazol-1-yl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-6-((4-(bicyclo[1.1.1]pentan-1-yl)-1H-1,2,3-triazol-1-yl)methyl)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxy-6-((4-(1-methylcyclopropyl)-1H-1,2,3-triazol-1-yl)methyl)tetrahydro-2H-pyran-3-ol; or

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxy-6-((4-(1-methylcyclobutyl)-1H-1,2,3-triazol-1-yl)methyl)tetrahydro-2H-pyran-3-ol;

or a pharmaceutically acceptable salt thereof.

9 . A compound according to claim 1 , wherein said compound is:

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-6-((1-(3-(fluoromethyl) oxetan-3-yl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-6-((1-(3-(difluoromethyl) oxetan-3-yl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxy-6-((1-(3-(trifluoromethyl)oxetan-3-yl)-1H-1,2,3-triazol-4-yl)methyl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-6-((1-((3R,4S)-3-fluorotetrahydro-2H-pyran-4-yl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-6-((1-((3R,4R)-4-fluorotetrahydrofuran-3-yl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-6-((1-((3S,4S)-4-fluorotetrahydrofuran-3-yl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-6-((1-((R)-3,3-difluorotetrahydro-2H-pyran-4-yl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-6-((1-((S)-3,3-difluorotetrahydro-2H-pyran-4-yl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-6-((1-((R)-4,4-difluorotetrahydrofuran-3-yl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-6-((1-((S)-4,4-difluorotetrahydrofuran-3-yl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-6-((1-((3S,4R)-3-fluorotetrahydro-2H-pyran-4-yl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxy-4-(4-(2,3,4-trifluorophenyl)-1H-1,2,3-triazol-1-yl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-6-((1-((3R,4S)-3-fluorotetrahydro-2H-pyran-4-yl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxy-4-(4-(2,3,4-trifluorophenyl)-1H-1,2,3-triazol-1-yl)tetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-6-((1-((3R,4R)-3-fluorotetrahydro-2H-pyran-4-yl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-chloro-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-6-((1-((3S,4S)-3-fluorotetrahydro-2H-pyran-4-yl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-bromo-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-6-((1-(3-(difluoromethyl) oxetan-3-yl)-1H-1,2,3-triazol-4-yl)methyl)-2-(hydroxymethyl)-5-methoxytetrahydro-2H-pyran-3-ol;

(2R,3R,4S,5R,6R)-4-(4-(4-bromo-2,3-difluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)-5-methoxy-6-((1-(3-(trifluoromethyl)oxetan-3-yl)-1H-1,2,3-triazol-4-yl)methyl)tetrahydro-2H-pyran-3-ol;

2,3-difluoro-4-(1-((2R,3R,4S,5R,6R)-2-((1-((3R,4S)-3-fluorotetrahydro-2H-pyran-4-yl)-1H-1,2,3-triazol-4-yl)methyl)-5-hydroxy-6-(hydroxymethyl)-3-methoxytetrahydro-2H-pyran-4-yl)-1H-1,2,3-triazol-4-yl) benzonitrile; or

2,3-difluoro-4-(1-((2R,3R,4S,5R,6R)-2-((1-((3S,4R)-3-fluorotetrahydro-2H-pyran-4-yl)-1H-1,2,3-triazol-4-yl)methyl)-5-hydroxy-6-(hydroxymethyl)-3-methoxytetrahydro-2H-pyran-4-yl)-1H-1,2,3-triazol-4-yl) benzonitrile;

or a pharmaceutically acceptable salt thereof.

10 . A pharmaceutical composition comprising a compound according to claim 1 , or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

11 - 13 . (canceled)

14 . A method for the prophylaxis or treatment of fibrosis of organs; liver diseases and disorders; acute kidney injury and chronic kidney disease; cardiovascular diseases and disorders; interstitial lung diseases and disorders; cell proliferative diseases and cancers; inflammatory and autoimmune diseases and disorders; gastrointestinal tract diseases and disorders; pancreatic diseases and disorders; abnormal angiogenesis-associated diseases and disorders; brain-associated diseases and disorders; neuropathic pain and peripheral neuropathy; ocular diseases and disorders; or transplant rejection; comprising administering to a subject in a need thereof an effective amount of a compound as defined in claim 1 , or of a pharmaceutically acceptable salt thereof.

15 . A pharmaceutical composition comprising a compound according to claim 8 , or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

16 . A pharmaceutical composition comprising a compound according to claim 9 , or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

17 . A method for the prophylaxis or treatment of fibrosis of organs; liver diseases and disorders; acute kidney injury and chronic kidney disease; cardiovascular diseases and disorders; interstitial lung diseases and disorders; cell proliferative diseases and cancers; inflammatory and autoimmune diseases and disorders; gastrointestinal tract diseases and disorders; pancreatic diseases and disorders; abnormal angiogenesis-associated diseases and disorders; brain-associated diseases and disorders; neuropathic pain and peripheral neuropathy; ocular diseases and disorders; or transplant rejection; comprising administering to a subject in a need thereof an effective amount of a compound as defined in claim 8 , or of a pharmaceutically acceptable salt thereof.

18 . A method for the prophylaxis or treatment of fibrosis of organs; liver diseases and disorders; acute kidney injury and chronic kidney disease; cardiovascular diseases and disorders; interstitial lung diseases and disorders; cell proliferative diseases and cancers; inflammatory and autoimmune diseases and disorders; gastrointestinal tract diseases and disorders; pancreatic diseases and disorders; abnormal angiogenesis-associated diseases and disorders; brain-associated diseases and disorders; neuropathic pain and peripheral neuropathy; ocular diseases and disorders; or transplant rejection; comprising administering to a subject in a need thereof an effective amount of a compound as defined in claim 9 , or of a pharmaceutically acceptable salt thereof.

Assignments (2)
PATENT SECURITY AGREEMENT Recorded Jun 25, 2026
From: IDORSIA PHARMACEUTICALS LTD
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 076038/0461 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2023
From: BOLLI, MARTIN; GATFIELD, JOHN; GRISOSTOMI, CORINNA; REMEN, LUBOS; SAGER, CHRISTOPH; ZUMBRUNN, CORNELIA
To: IDORSIA PHARMACEUTICALS LTD
Reel/Frame 064791/0308 →